MTHFD2 and cancer: In summary, MTHFD2 upregulation can be driven by various transcriptional, including mTORC1, MYC or Wnt/β-catenin signaling, post-transcriptional and post-translational mechanisms, although the mechanistic basis of this regulation appears to be cancer type specific.